While the primary reason hospitals adopt new technology is to increase patient care and produce better outcomes, there are many other factors that also affect purchasing decisions.
September 1, 2008 - More than 22 million people worldwide suffer from heart failure, and most heart failure hospitalizations are due to excessive fluid accumulation in the chest cavity, and new data presented at the European Society of Cardiology Congress this week shows Medtronic’s devices equipped with OptiVol Fluid Status Monitoring Alerts may give advance warning of a patients’ worsening c
Spectranetics Corp. recently announced the availability of its LLD EZ Lead Locking Device (LLD) for the removal of ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
TRUMPF Medical Systems Inc. offers an in-light high-definition (HD) operating room camera, the TruVidia HD, which ...
St. Jude Medical’s Promote RF CRT-D (cardiac resynchronization therapy defibrillator) and Current RF ICD (implantable cardioverter defibrillator) are radiofrequency (RF) wireless devices used to treat patients with heart failure and with potentially lethal heart arrhythmias.
September 2, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used primarily in cardiology and radiology procedures, today said five new products are scheduled to be introduced over the next few months.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 2, 2008 – The European Society of Cardiology (ESC) released new guidelines for how doctors should handle an acute pulmonary embolism (PE), during its 2008 Congress in Munich, Germany today.
September 3, 2008 - Edwards Lifesciences Corp. today said it received FDA approval for the Carpentier-Edwards PERIMOUNT ...
September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Edwards Lifesciences Corp. produces the Carpentier-Edwards The PERIMOUNT Magna mitral valve was launched in Europe in September 2005. It incorporates features of the Carpentier-Edwards PERIMOUNT mitral valve, which has demonstrated 16 years of durability, including the treatment of the bovine pericardial tissue leaflets with the Carpentier-Edwards ThermaFix process. September 2008
September 1, 2008 - Depression and heart disease are the two leading disorders with the strongest contributions to the ...
September 2, 2008 - Data from the landmark SYNTAX trial indicates patients with very complex coronary artery disease can ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Ovalum will feature its CiTop ExPander Guidewire at TCT 2008. According to the company, the guidewire was recently used ...
September 2, 2008 – Two recent studies demonstrate the economical value of cardiac imaging, showing MDCT to be cost ...
September 2, 2008 - Boston Scientific Corp. this past week said the U.S. District Court of Marshall, TX found two ...
September 03, 2008
